According to Novavax's latest financial reports the company's current earnings are $0.68 Billion USD. , an increase over its 2023 earnings that were of -$0.53 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -$0.16 Billion | -70.39% |
2023 | -$0.53 Billion | -16.59% |
2022 | -$0.64 Billion | -62.58% |
2021 | -$1.7 Billion | 320.54% |
2020 | -$0.41 Billion | 234.22% |
2019 | -$0.13 Billion | -30.17% |
2018 | -$0.18 Billion | 1.69% |
2017 | -$0.17 Billion | -36.44% |
2016 | -$0.27 Billion | 70.4% |
2015 | -$0.16 Billion | 89.27% |
2014 | -$82.79 Million | 59.83% |
2013 | -$51.8 Million | 81.9% |
2012 | -$28.48 Million | 50.33% |
2011 | -$18.95 Million | |
2009 | -$37.39 Million | 8.8% |
2008 | -$34.36 Million | 18.01% |
2007 | -$29.12 Million | 18.33% |
2006 | -$24.61 Million | 168.31% |
2005 | -$9.18 Million | -62.51% |
2004 | -$24.47 Million | 52.4% |
2003 | -$16.06 Million | -28.21% |
2002 | -$22.36 Million | |
2000 | -$12.75 Million | 177% |
1999 | -$4.6 Million | -11.54% |
1998 | -$5.2 Million | 10.64% |
1997 | -$4.7 Million | -9.62% |
1996 | -$5.2 Million |